BREITMEYER JAMES B - Insider Non-Derivative Transactions at Oncternal Therapeutics, Inc. (ONCT) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jan 3, 2024, BREITMEYER JAMES B's relationship to Oncternal Therapeutics, Inc. (ONCT) is Director,Officer (Chief Executive Officer), and currently has 443,034 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ONCT insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

BREITMEYER JAMES B - Insider Non-Derivative Transactions of ONCT Common Stock

BREITMEYER JAMES B - Insider Non-Derivative Transactions at ONCT

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jan 4, 2024	F -- (Common Stock)	4485	0.5	15426
Jan 4, 2024	F -- (Common Stock)	50955	0.5	443034
Jul 4, 2023	F -- (Common Stock)	4007	0.36	19911
Jul 4, 2023	F -- (Common Stock)	47992	0.36	493989
Apr 15, 2023	P -- (Common Stock)	47750	0.3	194294
Apr 15, 2023	P -- (Common Stock)	2250	0.29	196544
Apr 14, 2023	P -- (Common Stock)	100000	0.29	146544
Jan 4, 2023	F -- (Common Stock)	1325	1.02	23918
Jan 4, 2023	F -- (Common Stock)	27793	1.02	541981